- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Rivastigmine – July 2015
Rivastigmine; 13.3 mg/24 hours patch, 30; Exelon®
Last updated
30 October 2015